...
首页> 外文期刊>Annals of the New York Academy of Sciences >Dysregulation of the BMP-4 Signaling Pathway in Fibrodysplasia Ossificans Progressiva
【24h】

Dysregulation of the BMP-4 Signaling Pathway in Fibrodysplasia Ossificans Progressiva

机译:骨化性纤维增生症中BMP-4信号通路的失调

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Identification of gene mutations in Mendelian disorders is often determined by linkage analysis and positional cloning, an approach that is difficult for fibrodysplasia ossificans progressiva (FOP) due to a low reproductive fitness that results in a small number of multigen-erational families showing inheritance of the disease. Altered signaling pathways can be investigated as a complementary method to identify the consequences of the mutated gene responsible for FOP and to identify potential therapeutic targets. Candidate signaling pathways for FOP are those that malfunctioning could account for the malformation of the great toes during embryonic development and could explain the postnatal progressive heterotopic endochondral ossification. Signaling pathways that fit these criteria are the BMP signaling pathway and its interacting pathways. A large body of data suggest that the BMP-4 signaling pathway is dysregulated in FOP.
机译:孟德尔疾病中基因突变的鉴定通常是通过连锁分析和位置克隆来确定的,由于生殖适应性低,导致少数多代家庭显示出遗传性,因此难以进行骨化性纤维增生(FOP)。疾病。可以研究改变的信号通路作为一种补充方法,以鉴定负责FOP的突变基因的后果并确定潜在的治疗靶标。 FOP的候选信号通路是那些功能失常可能导致胚胎发育过程中大脚趾畸形并可以解释产后进行性异位软骨内骨化的信号通路。符合这些标准的信号传导途径是BMP信号传导途径及其相互作用的途径。大量数据表明BOP-4信号通路在FOP中失调。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号